Madrigal Pharmaceuticals, Inc. MDGL Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Segments
By geography
See fullOther financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (current)?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported operating lease liabilities (current) of $1.7M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (current) changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (current) increased by 67.0% year-over-year, from $1.02M to $1.7M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s operating lease liabilities (current) has grown at a 26.2% compound annual growth rate (CAGR), from $318K to $1.02M.
- What does operating lease liabilities (current) mean?
- The amount of lease payments due within the next year.
- How do you interpret operating lease liabilities (current)?
- Higher values indicate larger near-term cash outflows for facilities, which must be covered by existing cash reserves.
- How does operating lease liabilities (current) compare across companies?
- Standardized across industries under lease accounting standards (ASC 842).